Watertown, MA, United States of America

Sean M Rafferty

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sean M. Rafferty

Introduction

Sean M. Rafferty, an accomplished inventor based in Watertown, MA, has made significant contributions to the field of pharmaceutical innovations. With two patents to his name, his work primarily focuses on developing antiviral agents aimed at combating coronavirus infections.

Latest Patents

Sean M. Rafferty's recent patents include groundbreaking antiviral agents that target coronavirus replication activity. His first patent discloses compounds of Formula (I) and their pharmaceutically acceptable salts, which have demonstrated the potential to inhibit the replication of coronaviruses. Additionally, he has introduced methods for treating or preventing coronavirus infections through the administration of these compounds. Another patent that exemplifies his innovative spirit is centered around functionalized peptides as antiviral agents, further showcasing his dedication to developing effective pharmaceutical compositions that improve health outcomes for those in need.

Career Highlights

Rafferty's work is currently associated with Enanta Pharmaceuticals, Inc., a company that focuses on developing novel therapeutics for infectious diseases. His expertise in the field has contributed to advancing the company's mission of creating effective treatments for viral infections.

Collaborations

Within the realm of innovation, Sean collaborates with notable colleagues including Joseph D. Panarese and Nathaniel Thomas Kenton. These partnerships highlight the importance of teamwork in driving forward research initiatives and achieving successful outcomes in the development of new pharmaceutical agents.

Conclusion

Sean M. Rafferty stands out as a significant figure in pharmaceutical innovation, with his impactful patents addressing critical health challenges posed by coronaviruses. His ongoing work at Enanta Pharmaceuticals, coupled with collaborative efforts, underscores his commitment to improving public health through inventive solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…